礼来制药美股盘初跌1.85%,该公司将以至多25亿美元收购Scorpion的乳腺癌临床研究项目,从而扩充自身的肿瘤学管线。

金融界
13 Jan
礼来制药美股盘初跌1.85%,该公司将以至多25亿美元收购Scorpion的乳腺癌临床研究项目,从而扩充自身的肿瘤学管线。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10